Elanco Animal Health Incorporated Common Stock (ELAN)
Frequently Asked Questions About Elanco Animal Health Incorporated Common Stock (ELAN)
How can investors learn more about Elanco?
Investors can learn more about Elanco by visiting the company's official website, where they can find corporate news, financial reports, and presentations. Additionally, Elanco provides updates through its investor relations pages which include events and earnings calls.
How does Elanco address antibiotic resistance?
Elanco addresses antibiotic resistance through responsible use of antibiotics in livestock and pets, promoting alternatives such as vaccines and nutraceuticals. The company advocates for best practices in antibiotic stewardship to ensure both animal and human health is safeguarded.
How does Elanco contribute to animal welfare?
Elanco contributes to animal welfare by developing products that improve the health and well-being of animals. Their commitment to research and development ensures that they provide effective treatments and preventive care, enhancing the quality of life for both livestock and pets.
How does Elanco support veterinarians?
Elanco supports veterinarians through continued education programs, providing access to the latest research and treatment options, and offering marketing support to help veterinarians deliver the best care to their clients and their patients.
Is Elanco a publicly traded company?
Yes, Elanco Animal Health is publicly traded on the New York Stock Exchange under the ticker symbol ELAN. The company's shares are available for purchase by individual and institutional investors.
What are Elanco's major growth strategies?
Elanco's major growth strategies include expanding its product portfolio through innovation, pursuing strategic acquisitions, and enhancing customer relationships. The company focuses on growing its presence in emerging markets to reach new customer segments.
What does Elanco Animal Health do?
Elanco Animal Health is a global leader in animal health, providing a range of products and services to enhance the health of livestock and pets. The company focuses on developing innovative solutions for diseases prevention, treatment, and management in animals, improving both animal welfare and productivity.
What initiatives does Elanco have in place for corporate social responsibility?
Elanco has several initiatives aimed at corporate social responsibility, including improving food security, enhancing animal welfare practices, and supporting local communities. The company is committed to operating sustainably while contributing positively to society.
What is Elanco's approach to innovation?
Elanco's approach to innovation involves investing heavily in research and development to identify gaps in the market. The company collaborates with universities, research institutions, and key industry players to foster new ideas and solutions for animal health challenges.
What is Elanco's commitment to sustainability?
Elanco is committed to sustainability and responsible practices in animal agriculture. The company aims to reduce the environmental impact of livestock production while improving animal health and productivity through innovative products and methodologies.
What is Elanco's financial performance like?
Elanco's financial performance has shown steady growth since its spin-off, driven by innovation and expanding market share. The company continually evaluates its financial strategies to support sustainable growth and shareholder value.
What is Elanco's vision for the future?
Elanco envisions a future where companion and farm animals live healthier lives, which in turn supports the health of people and the planet. The company is committed to enhancing animal health and welfare while delivering value to its stakeholders and communities.
What is the focus of Elanco's research and development?
Elanco's research and development focus on creating innovative solutions to prevent and treat diseases in animals. This includes developing new therapies, vaccines, and products that enhance animal health, welfare, and productivity.
What is the significance of Elanco’s spin-off from Eli Lilly?
The spin-off from Eli Lilly allowed Elanco to operate as a standalone entity, focusing entirely on animal health. This separation provided the company with the autonomy to pursue its vision and growth strategies in the rapidly evolving animal health sector.
What markets does Elanco serve?
Elanco serves a global market, offering products in regions including North America, Europe, Latin America, Asia, and Africa. The company targets both large-scale farms for livestock and pet owners, ensuring their products meet diverse customer needs.
What types of products does Elanco offer?
Elanco offers a diverse portfolio of products, including vaccines, parasiticides, antibiotics, and nutritional health products. Their products cater to both livestock, such as cattle and poultry, and companion animals like dogs and cats.
When was Elanco founded?
Elanco was founded in 1954 as a division of Eli Lilly and Company. It became an independent company after being spun off from Eli Lilly in 2018, allowing it to focus exclusively on products and services for animal health.
Where is Elanco headquartered?
Elanco is headquartered in Greenfield, Indiana, USA. The location provides strategic access to key markets and allows the company to efficiently manage its global operations.
Who are Elanco's main competitors?
Elanco competes with several leading animal health companies, including Zoetis, Merck Animal Health, and Boehringer Ingelheim. These companies also focus on developing pharmaceuticals and vaccines for livestock and companion animals.
What is the current price of Elanco Animal Health Incorporated Common Stock?
The current price of Elanco Animal Health Incorporated Common Stock is 9.720
When was Elanco Animal Health Incorporated Common Stock last traded?
The last trade of Elanco Animal Health Incorporated Common Stock was at 4:10 pm EDT on April 3rd, 2025
What is the market capitalization of Elanco Animal Health Incorporated Common Stock?
The market capitalization of Elanco Animal Health Incorporated Common Stock is 4.81B
How many shares of Elanco Animal Health Incorporated Common Stock are outstanding?
Elanco Animal Health Incorporated Common Stock has 494.40M shares outstanding.